US Patent Issued to Novartis, The Trustees of the University of Pennsylvania on July 1 for "CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell" (Massachusetts, California, Pennsylvania, Maryland Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,657, issued on July 1, was assigned to Novartis AG (Basel, Switzerland) and The Trustees of the University of Pennsylvania (Philadelphia).

"CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell" was invented by Hans Bitter (Lincoln, Mass.), Jennifer Mary Bordeaux (Carlsbad, Calif.), Barbara Brannetti (Cambridge, Mass.), Jennifer Brogdon (Sudbury, Mass.), Naveen Kumar Dakappagari (Carlsbad, Calif.), Saar Gill (Philadelphia), Steven Highfill (Bethesda, Md.), Lu Huang (West Roxbury, Mass.), Carl H. June (Merion Station, Pa.), Ju Young Kim (Carlsbad, Calif.), Ming Lei (Acton, Mass.), Na Li (Cambridge, Mass.), Andreas Loew ...